Evidence map›Paper›PMID 40255254›Full record

ArticleIn silico pharmacology2025

In silico analysis of zosurabalpin-LptB2FG binding in

Meryam Magri, Rachid Eljaoudi, Lahcen Belyamani, Azeddine Ibrahimi, El Mehdi Bouricha

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in In silico pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Membrane-Focused Strategies AgainstAntibiotics (Basel, Switzerland) · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Meryam MagriMedical Biotechnology Laboratory (MedBiotech), Faculty of Medicine and Pharmacy of Rabat, Mohammed Vth University in Rabat, Rabat, Morocco.
Rachid EljaoudiMedical Biotechnology Laboratory (MedBiotech), Faculty of Medicine and Pharmacy of Rabat, Mohammed Vth University in Rabat, Rabat, Morocco.
Lahcen BelyamaniMohammed VI University of Sciences and Health (UM6SS), Casablanca, Morocco.
Azeddine IbrahimiMedical Biotechnology Laboratory (MedBiotech), Faculty of Medicine and Pharmacy of Rabat, Mohammed Vth University in Rabat, Rabat, Morocco.
El Mehdi BourichaMohammed VI University of Sciences and Health (UM6SS), Casablanca, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zosurabalpin, a novel tethered macrocyclic peptide antibiotic, exhibits potent activity against Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-025-00343-3.

Indexed as

Acinetobacter baumanniiKlebsiella pneumoniaeLptB2FG proteinShigella flexneriZosurabalpin

Identifiers

PMID40255254
PMCPMC12003254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.